I MAB's ticker is IMAB and the CUSIP is 44975P103. A total of 49 filers reported holding I MAB in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,305,059 | -1.7% | 988,681 | +122.6% | 0.00% | – |
Q2 2023 | $1,328,128 | -65.6% | 444,190 | -60.2% | 0.00% | – |
Q1 2023 | $3,858,494 | -42.0% | 1,115,172 | -29.9% | 0.00% | -100.0% |
Q4 2022 | $6,651,514 | -12.4% | 1,591,271 | -15.9% | 0.00% | 0.0% |
Q3 2022 | $7,589,000 | -71.7% | 1,892,804 | -20.3% | 0.00% | -66.7% |
Q2 2022 | $26,847,000 | +1.8% | 2,375,968 | +46.3% | 0.00% | -25.0% |
Q1 2022 | $26,381,000 | -61.8% | 1,624,408 | +11.4% | 0.00% | -55.6% |
Q4 2021 | $69,112,000 | -33.5% | 1,458,356 | +1.7% | 0.01% | -35.7% |
Q3 2021 | $103,937,000 | +162.3% | 1,433,812 | +203.7% | 0.01% | +180.0% |
Q2 2021 | $39,629,000 | +253.5% | 472,047 | +104.1% | 0.01% | +150.0% |
Q1 2021 | $11,212,000 | +25.7% | 231,306 | +22.2% | 0.00% | +100.0% |
Q4 2020 | $8,923,000 | +17.3% | 189,236 | +17.0% | 0.00% | 0.0% |
Q3 2020 | $7,607,000 | +45.1% | 161,753 | -7.6% | 0.00% | 0.0% |
Q2 2020 | $5,242,000 | +130.4% | 175,129 | +0.1% | 0.00% | 0.0% |
Q1 2020 | $2,275,000 | – | 175,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sage Partners Ltd | 2,054 | $23,000 | 100.00% |
Cederberg Capital Ltd | 2,215,385 | $25,034,000 | 6.63% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 6,232 | $553,000,000 | 5.77% |
IvyRock Asset Management (HK) Ltd | 613,356 | $6,931,000 | 4.38% |
Zeal Asset Management Ltd | 194,538 | $2,060,000 | 4.25% |
EDBI Pte Ltd | 222,136 | $2,510,000 | 2.33% |
HHLR ADVISORS, LTD. | 7,182,850 | $81,166,000 | 1.74% |
Old Well Partners, LLC | 125,325 | $1,416,000 | 1.13% |
ARMISTICE CAPITAL, LLC | 3,324,000 | $37,561,000 | 0.66% |
Maso Capital Partners Ltd | 100,000 | $1,130,000 | 0.64% |